awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34451624-204C62BE-77C0-4150-B814-D7E5DFC708ED
Q34451624-204C62BE-77C0-4150-B814-D7E5DFC708ED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34451624-204C62BE-77C0-4150-B814-D7E5DFC708ED
Extensive pleural and pericardial effusion in chronic myeloid leukemia during treatment with dasatinib at 100 mg or 50 mg daily
P2860
Q34451624-204C62BE-77C0-4150-B814-D7E5DFC708ED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34451624-204C62BE-77C0-4150-B814-D7E5DFC708ED
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
63e6523376aed50707b20bff2474cae5c3e97f7e
P2860
Intermittent target inhibition with dasatinib 100 mg once daily preserves efficacy and improves tolerability in imatinib-resistant and -intolerant chronic-phase chronic myeloid leukemia.